Global Serotonin Norepinephrine Inhibitor Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Mood Disorders & Anxiety Disorders
The global Serotonin Norepinephrine Inhibitor market is estimated to be valued at US$ 6.29 billion in 2022 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Serotonin Norepinephrine Inhibitors are a class of drugs used to treat mood disorders, including depression and anxiety. They...
0 Comments 0 Shares 1547 Views 0 Reviews
Sponsored